Report Categories Report Categories

Report Categories

industry Category

All

Total: 6 records, 1 pages

Global Oral Mucositis Drugs Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs

The global Oral Mucositis Drugs market size is expected to reach $ 1501.1 million by 2030, rising at a market growth of 7.2% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Oral Mucositis Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs

According to our (Global Info Research) latest study, the global Oral Mucositis Drugs market size was valued at USD 924 million in 2023 and is forecast to a readjusted size of USD 1501.1 million by 2030 with a CAGR of 7.2% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Oral Mucositis Drugs for Cancer Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 21 Jan 2024

date Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs for Cancer Therapy

According to our (Global Info Research) latest study, the global Oral Mucositis Drugs for Cancer Therapy market size was valued at USD 184.6 million in 2023 and is forecast to a readjusted size of USD 259.3 million by 2030 with a CAGR of 5.0% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Oral Mucositis Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs

Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.

USD3480.00

Add To Cart

Add To Cart

Global Oral Mucositis Drugs for Cancer Therapy Supply, Demand and Key Producers, 2023-2029

date 05 Feb 2023

date Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs for Cancer Therapy

The global Oral Mucositis Drugs for Cancer Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Oral Mucositis Drugs for Cancer Therapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 03 Jan 2023

date Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs for Cancer Therapy

Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.

USD3480.00

Add To Cart

Add To Cart

industry 10 Feb 2024

industry Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs

The global Oral Mucositis Drugs market size is expected to reach $ 1501.1 million by 2030, rising at a market growth of 7.2% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs

According to our (Global Info Research) latest study, the global Oral Mucositis Drugs market size was valued at USD 924 million in 2023 and is forecast to a readjusted size of USD 1501.1 million by 2030 with a CAGR of 7.2% during review period.

USD3480.00

addToCart

Add To Cart

industry 21 Jan 2024

industry Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs for Cancer Therapy

According to our (Global Info Research) latest study, the global Oral Mucositis Drugs for Cancer Therapy market size was valued at USD 184.6 million in 2023 and is forecast to a readjusted size of USD 259.3 million by 2030 with a CAGR of 5.0% during review period.

USD3480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs

Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.

USD3480.00

addToCart

Add To Cart

industry 05 Feb 2023

industry Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs for Cancer Therapy

The global Oral Mucositis Drugs for Cancer Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 03 Jan 2023

industry Pharma & Healthcare

new_biaoQian Oral Mucositis Drugs for Cancer Therapy

Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.

USD3480.00

addToCart

Add To Cart